Abdulah Alrifai is a Cardiology physician affiliated with Advocate Heart Institute. OpenAlex indexes 42 publications with 441 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
17850 Kedzie Ave Ste 3250
Hazel Crest, IL 604292082
Telephone
561-548-1450Provider last certified this registry record 15 Oct 2025.
Industry payments
30 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Surmodics, Inc.Program year202511 payments
- Penumbra, Inc.Program year20253 payments
- Imperative Care, IncProgram year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
77.8%Beta blocker19.5%Carvedilol38%Metoprolol Succinate35%Metoprolol Tartrate27%Part D≥42 patientsStatin18.4%Atorvastatin Calcium70%Rosuvastatin Calcium19%Pravastatin Sodium8%Lovastatin4%Part D<11 patients+ 11 more classes in this area
Blood & clotting
19.6%P2Y12 inhibitor9.2%Clopidogrel100%Part D≥54 patientsFactor Xa inhibitor7%Eliquis85%Xarelto15%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
2.6%SGLT2 inhibitor1.8%Jardiance100%Part D≥11 patientsPotassium supplement0.9%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Delivering Multidisciplinary Cardiac Care in Conflict Zones: A Cardiology Mission to Homs, Syria
Journal of the Society for Cardiovascular Angiography & Interventions
2025 - Diagnosis, Treatment and Follow Up of Acute Pulmonary Embolism: Consensus Practice from the PERT Consortium
Clinical and Applied Thrombosis/Hemostasis
2019 - Dual antiplatelet therapy versus single antiplatelet therapy after transaortic valve replacement: Meta-analysis
Cardiovascular revascularization medicine
2018 - Long‐term quality of life in octogenarians and nonagenarians with nonvalvular atrial fibrillation following WATCHMAN™ device implantation
Catheterization and Cardiovascular Interventions
2018
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”